Latest Breaking News On - Cat tm cell adherent technology - Page 1 : comparemela.com

MedAlliance Announces Enrollment of over 1,660 Patients in Landmark

MedAlliance has announced enrollment of over 1,660 patients in its ground breaking SELUTION DeNovo coronary randomized

Switzerland generalUnited statesFrance generalLanguedoc roussillonRichard kenyonChristian spauldingParis cite universityCat tm cell adherent technologyCardiology departmentEuropean hospital georgesAssistance publique hopitaux de parisSafety monitoring boardMedalliance chairmanCell adherent technologyMiddle east

MedAlliance announces the completion of enrollment in SAVE Trial with SELUTION SLR for Treatment of AV Fistulas in Renal Dialysis Patients

MedAlliance has announced completion of patient enrollment in the SAVE Clinical Trial with the SELUTION SLR(TM) 018 DEB (drug-eluting balloon) for the treatment of failed AVF (arteriovenous fistulas) in renal dialysis patients. SELUTION SLR is a

Switzerland generalUnited statesRichard kenyonKonstantinos katsanosPatras university hospitalCat tm cell adherent technologySelution sirolimus eluting balloonEss treatment indicationsPrincipal investigatorAssociate professorInterventional radiologyCell adherent technologyMiddle east

MedAlliance announces completion of enrollment in Japanese SELUTION SLR(TM)

MedAlliance announces completion of enrollment in Japanese SELUTION SLR(TM)
ryt9.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ryt9.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSwitzerland generalRichard kenyonMa med allianceCat tm cell adherent technologyDevice agencySirolimus drug eluting balloonClinical trial notificationMedical device agencyMajor adversePrimary patencyMedalliance chairmanCell adherent technology